drugset
drugset / Trial / NCT03696745

The Treatment of Premature Infants With Brain Injury by Autologous Umbilical Cord Blood Stem Cells

NCT03696745 ↗

Phase 1 Unknown 200 enrolled Guangdong Women and Children Hospital
Non-randomizedParallel-groupOpen-labelTreatment

Summary

To study the safety and effect of autologous umbilical cord blood stem cells for treatment brain injury

Timeline

Start
2018-11-01
Primary completion
2020-09-01
Completion
2021-09-01

Drugs

EvaluationDrugModalityDoseRoute
Subject autologous umbilical cord blood stem cells Cell therapy 5e+07 cells/kg —

Indications

No indication recorded.